The EPIC-NSW management team welcomes the announcement by the Commonwealth Health Minister of the listing of co-formulated tenofovir and emtricitabine for PrEP on the Pharmaceutical Benefits Scheme from 1st April 2018. The EPIC-NSW management team will be in touch with each EPIC-NSW clinic in the coming weeks with more details about transitional arrangements. Please continue… Read More
Continue Reading